dupilumab (dupixent) Report issue

Biologics mAb Approved FDA First in Class
AACT ChEMBL DrugBank Drugs@FDA MeSH
Back

Drug Pricing Summary

AUS PBS

$645.0496

VA Big4

$1079.2200 - $2556.0624

VA FSS

$1500.3450 - $3321.1506

NADAC

$1543.6372 - $1557.7792

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
dupilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $645.0496 AUS PBS generic
  • Dupixent (2)
    		•  sanofi-aventis Australia Pty Ltd
    dupilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $1557.7792 NADAC brand
  • Dupixent (0.9)
    		•  sanofi-aventis U.S. LLC
    dupilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $2556.0624 VA Big4
  • Dupixent (0.9)
    		•  Sanofi Aventis U.S. LLC
    dupilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $3321.1506 VA FSS
  • Dupixent (0.9)
    		•  Sanofi Aventis U.S. LLC
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $645.0496 AUS PBS generic
  • Dupixent (2)
    		•  sanofi-aventis Australia Pty Ltd
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $1079.2200 VA Big4
  • Dupixent (2)
    		•  Sanofi Aventis U.S. LLC
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $1500.3450 VA FSS
  • Dupixent (2)
    		•  Sanofi Aventis U.S. LLC
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $1543.6372 NADAC brand
  • Dupixent (0.5)
    		•  sanofi-aventis U.S. LLC
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $2213.8900 VA Big4
  • Dupixent (1)
    		•  Sanofi Aventis U.S. LLC
    dupilumab 300 mg / 2 mL (2 mL INJECTION) $2946.5700 VA FSS
  • Dupixent (1)
    		•  Sanofi Aventis U.S. LLC

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue